Trial intelligence / Profile preview

Digoxin vs Ivabradine in HFpEF with AF

NCT01699776Phase 4Completed

Start
Apr 2008
Primary completion
Feb 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ivabradine in heart failure with preserved ejection fraction (HFpEF), Atrial fibrillation (AFib). Started Apr 2008; status: completed.

02

Drugs

ivabradine
03

Conditions

heart failure with preserved ejection fraction (HFpEF)Atrial fibrillation (AFib)

Beyond the preview

Go deeper on NCT01699776.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01699776.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call